Reply to "Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection".
作者信息
Jones Jefferson M, Coughlin Melissa M, Grebe Eduard, Busch Michael P, Clarke Kristie E N
机构信息
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Vitalant Research Institute, San Francisco, California, USA.
出版信息
Microbiol Spectr. 2025 Feb 4;13(2):e0197924. doi: 10.1128/spectrum.01979-24. Epub 2024 Dec 16.
Abstract
摘要
相似文献
1
Reply to "Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection".对《疫苗接种导致严重急性呼吸综合征冠状病毒2感染累计发病率估计偏低》的回复
Microbiol Spectr. 2025 Feb 4;13(2):e0197924. doi: 10.1128/spectrum.01979-24. Epub 2024 Dec 16.
2
Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection.疫苗接种导致对SARS-CoV-2感染累积发病率的低估。
Microbiol Spectr. 2025 Feb 4;13(2):e0155824. doi: 10.1128/spectrum.01558-24. Epub 2024 Dec 16.
3
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies.鉴于抗体水平下降，估算新型冠状病毒2型（SARS-CoV-2）感染的累积发病率和感染致死率。
medRxiv. 2020 Nov 16:2020.11.13.20231266. doi: 10.1101/2020.11.13.20231266.
4
Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies.根据抗体衰减情况估计 SARS-CoV-2 感染的累积发病率和感染病死率。
Epidemiology. 2021 Jul 1;32(4):518-524. doi: 10.1097/EDE.0000000000001361.
5
Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study.应用机器学习预测个体 SARS-CoV-2 疫苗接种和感染状态在 2020 年 3 月至 2022 年法国血清学监测调查中的应用：横断面研究。
JMIR Public Health Surveill. 2023 Nov 28;9:e46898. doi: 10.2196/46898.
6
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.2021 年 8 月，挪威人群中针对 SARS-CoV-2 的抗体流行率。
Influenza Other Respir Viruses. 2022 Nov;16(6):1004-1013. doi: 10.1111/irv.13024. Epub 2022 Jun 30.
7
Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: A repeated cross-sectional survey, 2021-2022.赞比亚首次产前检查孕妇中新冠病毒2型血清流行趋势：2021 - 2022年重复横断面调查
PLOS Glob Public Health. 2024 Apr 3;4(4):e0003073. doi: 10.1371/journal.pgph.0003073. eCollection 2024.
8
Increased breadth and neutralization of antibodies against SARS-CoV-2 variants after infection and vaccination: A serosurveillance study in pediatric patients of Southern Switzerland.感染和接种疫苗后对 SARS-CoV-2 变体的抗体的广度和中和能力增强：瑞士南部儿科患者的血清学监测研究。
Eur J Pediatr. 2024 Mar;183(3):1425-1434. doi: 10.1007/s00431-023-05400-7. Epub 2024 Jan 4.
9
SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.SARS-CoV-2 感染率、血清流行率和无家可归人群中的 COVID-19 疫苗接种率：系统评价和荟萃分析。
Front Public Health. 2023 Oct 10;11:1044788. doi: 10.3389/fpubh.2023.1044788. eCollection 2023.
10
Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21.2020/21 年冬季挪威疫苗接种前成年人人群中针对 SARS-CoV-2 的抗体血清阳性率。
Euro Surveill. 2022 Mar;27(13). doi: 10.2807/1560-7917.ES.2022.27.13.2100376.
本文引用的文献
1
Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors.检测未接种疫苗和接种疫苗的献血者中与原发性 SARS-CoV-2 感染相关的核衣壳抗体。
Emerg Infect Dis. 2024 Aug;30(8):1621-1630. doi: 10.3201/eid3008.240659. Epub 2024 Jul 9.
2
Comparison of SARS-CoV-2 seroprevalence estimates between commercial lab serum specimens and blood donor specimens, United States, September-December 2021.2021年9月至12月美国商业实验室血清标本与献血者标本中新冠病毒血清流行率估计值的比较
Microbiol Spectr. 2024 Aug 6;12(8):e0012324. doi: 10.1128/spectrum.00123-24. Epub 2024 Jun 13.
3
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications.用于 SARS-CoV-2 血清学监测应用的 Ortho VITROS 和 Roche Elecsys S 和 NC 免疫分析的评估。
Microbiol Spectr. 2023 Aug 17;11(4):e0323422. doi: 10.1128/spectrum.03234-22. Epub 2023 Jun 22.
4
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.奥密克戎变异株流行期间抗SARS-CoV-2核衣壳蛋白抗体对突破性感染的敏感性。
J Infect. 2022 Nov;85(5):573-607. doi: 10.1016/j.jinf.2022.08.015. Epub 2022 Aug 20.
5
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.SARS-CoV-2 感染后抗核衣壳抗体在随机、安慰剂对照的 mRNA-1273 COVID-19 疫苗疗效临床试验的盲法阶段。
Ann Intern Med. 2022 Sep;175(9):1258-1265. doi: 10.7326/M22-1300. Epub 2022 Jul 5.
6
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.评估市售高通量 SARS-CoV-2 血清学检测试剂盒在血清学监测及相关应用中的性能。
Emerg Infect Dis. 2022 Mar;28(3):672-683. doi: 10.3201/eid2803.211885.
Zotero 插件